New placental patch shows promise for diabetic foot ulcers
NCT ID NCT06511596
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a special placental membrane (BR-AC) to standard wound care helps heal diabetic foot ulcers faster. 71 adults with diabetes and foot ulcers were randomly assigned to get either standard care alone or standard care plus BR-AC. The main goal was to see if more ulcers closed completely within 12 weeks. People who didn't heal with standard care could later receive BR-AC.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BR-AC (a placental membrane made from amnion, intermediate, and chorion layers)
What this could lead to
If it works, this could offer a new option to help heal stubborn diabetic foot ulcers faster and reduce the risk of complications.
What could go wrong
This is a small, completed trial with only 71 participants. Results may not apply to everyone, and the treatment may not work better than standard care alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 01
Vista, California, 92081, United States
-
Site 02
San Francisco, California, 94115, United States
-
Site 03
Fort Worth, Texas, 76104, United States
-
Site 04
Sylmar, California, 91342, United States
-
Site 05
McAllen, Texas, 78501, United States
-
Site 06
O'Fallon, Illinois, 62269, United States
-
Site 07
Torrance, California, 90502, United States
-
Site 08
North Chicago, Illinois, 60064, United States
-
Site 09
Frisco, Texas, 75034, United States
-
Site 10
Westwood, New Jersey, 07675, United States
-
Site 11
Miami, Florida, 33175, United States